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Trophoblast differentiation during placentation involves an epithelial-mesenchymal transition (EMT) with
loss of E-cadherin and gain of trophoblast invasiveness. Mice harboring a point mutation that renders inactive
the mitogen-activated protein kinase kinase kinase MEKK4 exhibit dysregulated placental development with
increased trophoblast invasion. Isolated MEKK4 kinase-inactive trophoblast stem (TS) cells cultured under
undifferentiating, self-renewing conditions in the presence of fibroblast growth factor 4 (FGF4) display
increased expression of Slug, Twist, and matrix metalloproteinase 2 (MMP2), loss of E-cadherin, and hyper-
invasion of extracellular matrix, each a hallmark of EMT. MEKK4 kinase-inactive TS cells show a preferential
differentiation to Tpbp- and Gcm1-positive trophoblasts, which are indicative of spongiotrophoblast and
syncytiotrophoblast differentiation, respectively. FGF4-stimulated Jun N-terminal kinase (JNK) and p38
activity is markedly reduced in MEKK4 kinase-inactive TS cells. Chemical inhibition of JNK in wild-type TS
cells induced a similar EMT response as loss of MEKK4 kinase activity, including inhibition of E-cadherin
expression and increased expression of Slug, MMP2, Tpbp, and Gcm1. Chromatin immunoprecipitation
analyses revealed changes in AP-1 composition with increased Fra-2 and decreased Fra-1 and JunB binding to
the regulatory regions of Gcm1 and MMP2 genes in MEKK4 kinase-inactive TS cells. Our results define
MEKK4 as a signaling hub for FGF4 activation of JNK that is required for maintenance of TS cells in an
undifferentiated state.
Trophoblasts are the first cell type to be specified at the
blastocyst stage and differentiate to form the extraembryonic
epithelial cells of the placenta (20). Differentiation of tropho-
blast stem (TS) cells is necessary for trophoblast invasion of
the uterus for establishment of the placenta. Once implanta-
tion is complete, different trophoblast lineages assume specific
functions in the placenta. TS cell acquisition of the ability to
migrate and invade extracellular matrix required for placenta-
tion is a functional hallmark of epithelial-mesenchymal transi-
tion (EMT) (21). Once invasion is complete, the trophoblasts
assume an epithelial phenotype with loss of motility and inva-
siveness characteristic of a mesenchymal-epithelial transition
(MET) (9, 27). Other than the role of fibroblast growth factor
4 (FGF4) activation of ERK1/2 in controlling TS cell self-
renewal and survival, little is known about the signaling path-
ways controlling TS cell maintenance, suppression of the com-
mitment to an invasive phenotype, and differentiation (18,
22, 26).
We have found that MEKK4, a mitogen-activated protein
kinase kinase kinase (MAP3K) that regulates Jun N-terminal
kinase (JNK) and p38 activity, is expressed strongly in the
developing embryo, TS cells, and cells derived from TS cells.
Targeted mutation of the required active-site lysine renders
MEKK4 kinase inactive in murine ES cells (3) and results in
dramatic changes in embryonic development. Loss of MEKK4
kinase activity in developing mouse embryos results in lethality
due to both neural tube closure defects and skeletal malfor-
mations (3). Herein we show that extraembryonic development
is perturbed in MEKK4 kinase-inactive concepti, resulting in
disruptions in placental development. These defects are highly
penetrant in fetuses homozygous for kinase-inactive MEKK4
and are also observed with fetuses heterozygous for the mutant
MEKK4 allele because of the dominant negative properties of
the kinase-inactive MEKK4 protein.
Little is known about how growth factors control tissue stem
cell maintenance and self-renewal and signal to control inhi-
bition of differentiation. In this report we show that changes in
the regulation of TS cell differentiation account for the disrup-
tion in placental development seen with mice harboring ki-
nase-inactive MEKK4. We show that loss of MEKK4 kinase
activity in TS cells inhibits FGF4 activation of JNK and p38,
promoting the loss of E-cadherin expression, increased inva-
siveness, and expression of factors that promote selective TS
cell differentiation toward spongiotrophoblast and syncytiotro-
phoblast lineages. Chemical inhibition of JNK mimics many of
the changes observed in the kinase-inactive MEKK4 TS cells.
Thus, MEKK4 signaling to JNK is required for FGF4 to sup-
press TS cell EMT, invasiveness, and differentiation. The re-
sults show that MEKK4 is a key hub kinase that regulates the
fundamental decision of TS cells to undergo renewal for stem
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cell maintenance or to induce a program of increased motility,
invasiveness, and differentiation for placental development.
These findings show for the first time the requirement of
FGF4-stimulated MEKK4 activation of JNK for maintenance
of a tissue stem cell.
MATERIALS AND METHODS
Mouse strains and genotyping. MEKK4WT/K1361R mice (3) were maintained
on both mixed (C57BL/6  129/SvEv) and pure (129/SvEv) backgrounds. Pla-
centas and TS cells isolated from both mouse backgrounds yielded identical
results. PCR genotyping was used for mice, embryos, and TS cells as previously
described (3). All animal and embryo work was performed according to univer-
sity and federal guidelines for the use of animals.
Placental isolation and histology. Embryos and placentas were isolated at
embryonic day 7.5 (E7.5), E8.5, E9.5, and E13.5 from timed matings of either
wild-type or heterozygote MEKK4WT/K1361R mice. Embryos were used for geno-
typing. Placentas were fixed at 4°C overnight in 4% paraformaldehyde–phos-
phate-buffered saline (PBS) and frozen as previously described (3). Ten-mi-
crometer cryosections were used for analyses. Sections were stained with
hematoxylin and eosin using standard techniques.
In situ hybridization. In situ hybridizations were performed as described
previously (3, 24). Slides were incubated overnight at 66°C with digoxigenin-
labeled antisense probes for PlI, Tpbp, and Gcml, which were generated from
constructs provided as a kind gift by David Threadgill (UNC Chapel Hill).
Probes were detected with alkaline phosphatase-conjugated antidigoxigenin an-
tibodies (Boehringer Mannheim) and BM purple (Boehringer Mannheim).
Trophoblast stem cell isolation and primary cell culture. For wild-type and
heterozygote cells, TS cells were isolated using the method of Tanaka et al. from
blastocysts derived from timed matings of MEKK4WT/K1361R mice (22). TS cells
were cultured without feeders in 30% TS medium containing RPMI 1640, 20%
heat-inactivated fetal bovine serum, 1% sodium pyruvate, 1% penicillin-strepto-
mycin, 1% glutamine, and 100 M -mercaptoethanol and 70% conditioned
medium isolated from mitomycin-treated primary mouse embryonic fibroblasts
(MEFs) cultured in TS medium. Medium was supplemented with FGF4 (37.5
ng/ml) and heparin (1 mg/ml). MEFs were isolated from 129SvEv mice at E14.5
as previously described (3). For treatment with inhibitors, undifferentiated TS
cells were treated for 2 days with either dimethyl sulfoxide (DMSO), 50 M
SP600125 (JNK inhibitor), 10 M SB203580 (p38 inhibitor), or 10 M U0126
(MEK inhibitor). Tissue culture plastic was from Fisher, medium reagents were
from Gibco, and chemicals were from Sigma.
Immunofluorescence. For immunostaining of placental cryosections, sections
were washed in PBS and permeabilized for 5 minutes in 0.2% Triton in PBS.
Slides were washed and blocked in 10% donkey serum and incubated overnight
at 4°C in block containing rabbit anti-MEKK4 antibody (3), rat anti-PECAM
antibody (BD Pharmingen), and mouse anticytokeratin antibody (Sigma). Slides
FIG. 1. MEKK4 is expressed strongly in the trophoblast lineages of
the developing placenta. MEKK4 was visualized in cryosections with
anti-MEKK4 immunostaining (red) (A, C, D, H, and I) and by in situ
hybridization with MEKK4 antisense probe (purple) (B, E, and F) or
control MEKK4 sense probe (G). Nuclei were counterstained with
DAPI (blue). (A) Anti-MEKK4 immunostaining shows that MEKK4 is
expressed not only in the developing embryo but also in the invading
primary giant cells lining the implantation site and the ectoplacental
cone. (B) MEKK4 expression by in situ hybridization shows an iden-
tical expression pattern of MEKK4 message compared to the MEKK4
protein shown in panel A. (C and D) Strong MEKK4 expression in
E8.5 chorion visualized by anti-MEKK4 immunostaining. The box
indicates the area shown in the inset in panel D. (E) Strong expression
of MEKK4 message in E8.5 chorion by in situ hybridization with
antisense MEKK4 probe. (F) In situ hybridization with antisense
MEKK4 probe in an E9.5 cryosection. (G) Control in situ hybridiza-
tion with sense MEKK4 probe in an E9.5 cryosection. (H and I)
Anti-MEKK4 immunostaining of E9.5 placenta (red). A white box
indicates the area shown in the inset in panel I. For panels A to I,
closed arrows indicate trophoblast giant cells, open arrows indicate
spongiotrophoblasts, closed arrowheads indicate undifferentiated
cuboidal trophoblasts, and open arrowheads indicate chorion. (J to O)
Immunofluorescence microscopy of E9.5 placental cryosections
stained with an anti-MEKK4 antibody (red) and counterstained with
the nuclear stain DAPI (blue). (J to L) MEKK4 does not colocalize
with PECAM-positive endothelial cells. Sections were also costained
with anti-PECAM antibody (green). (M to O) MEKK4 colocalizes
with cytokeratin (CK). Sections were also costained with anti-CK an-
tibody. White boxes in panel J indicate the area that is enlarged in the
insets in panels K and L. White boxes in panel M indicate areas
enlarged in the insets in panels N and O. Filled arrowheads indicate
MEKK4 in undifferentiated cuboidal trophoblasts. For panels J to O,
filled arrows indicate PECAM-positive endothelial cells. Open arrows
indicate sites with CK staining (green) having colocalization with
MEKK4 (red). Bar, 100 m.
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were washed and incubated for 1 hour with fluorescently labeled secondary
antibodies (Jackson Immunoresearch) and 4,6-diamidino-2-phenylindole
(DAPI; Molecular Probes). TS cells were cultured on coverglasses for 2 days,
treated with DMSO or inhibitors for 2 days, and then fixed in 3% paraformal-
dehyde–PBS for 10 minutes. Coverslips were washed and permeabilized for 5
minutes in 0.2% Triton in PBS. After incubation for 1 hour in block, coverslips
were incubated overnight at 4°C in block containing mouse anti-E-cadherin
antibody (BD Transduction). Coverslips were washed and incubated for 1 hour
at room temperature in block containing Cy3-donkey anti-mouse secondary and
DAPI.
Western blotting of whole-cell and nuclear lysates. TS cells were washed once
with PBS and lysed on ice in buffer A containing 20 mM Tris (pH 7.4), 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton-X, 1 mM phenylmethylsulfonyl
fluoride, 1 mM sodium vanadate, 1 mM sodium fluoride, 0.05 mM dithiothreitol,
1 g/ml leupeptin, and 17 g/ml aprotinin A. Ten micrograms of lysate was
subjected to Western blotting with phospho-specific antibodies to JNK and p38
(Cell Signaling) or with antibodies recognizing total -tubulin (Sigma), -catenin
(Sigma), E-cadherin (BD Transduction), or MEKK3 (BD Transduction). Bands
were quantitated by densitometry using ImageJ.
For nuclear lysates, TS cells were washed once with PBS and scraped on ice in
homogenization buffer containing 10 mM HEPES (pH 7.4), 10 mM KCl, 1.5 mM
MgCl2, 0.1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium
vanadate, 0.05 mM dithiothreitol, 1 g/ml leupeptin, and 17 g/ml aprotinin A.
Cells were disrupted by five passages through a 25-gauge needle. Cells were spun
and pellets were washed with homogenization buffer. Pellets were extracted with
30 l of extraction buffer containing 10 mM HEPES (pH 7.4), 400 mM NaCl, 1.5
mM MgCl2, 0.1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium
vanadate, 0.05 mM dithiothreitol, 1 g/ml leupeptin, and 17 g/ml aprotinin A
with shaking at 4°C for 15 minutes. Pellets were spun for 15 minutes at 4°C and
5 g of the supernatant was analyzed by Western blotting for AP-1 transcription
family members using antibodies from Santa Cruz Biotechnology for Fra-1,
Fra-2, JunB, ATF-2, and c-Jun.
Quantitative real-time RT-PCR and chromatin immunoprecipitation (ChIP)
analyses. Total RNA was isolated from murine trophoblast stem cells using the
RNeasy minikit (Qiagen). The High-Capacity cDNA reverse transcription (RT)
kit (Applied Biosystems) was used to synthesize cDNA from 3 g of total RNA,
which was DNase treated only if the subsequent real-time assays were not
designed to detect mRNA exclusively. Real-time RT-PCR was performed on
diluted cDNA using the Applied Biosystems 7500 Fast real-time PCR system
(standard program) and either inventoried TaqMan gene expression assays or
Sybr green reagents with primer pairs designed using Primer Express software
version 3.0 (Applied Biosystems). Primer pairs for detecting murine proliferins 1
to 4 (PLF-1 to -4) and placental lactogen 1 (PL-1) with the Sybr green assay
were as follows: PLF 5 primer, TCAACCATGCTCCTGGATACTG; PLF 3
primer, GGCAACATTCTTCCACAATAACG; PL-1 5 primer, TTATCTTG
GCCGCAGATGTG; PL-1 3 primer, TCTGTCTGTTATCCAAGTTTTATC
GAA. Murine -actin served as the endogenous control, and undifferentiated
wild-type MEKK4 was the calibrator for calculating differences in expression
levels using the 2CT method. Final results represent the pooling of at least
two experiments in which cDNA was assayed in duplicate or triplicate.
For ChIP analyses, undifferentiated wild-type and kinase-inactive TS cells
were fixed for 10 minutes with 1% formaldehyde, sonicated, and immunopre-
cipitated with anti-Fra-1, -Fra-2, and -JunB antibodies. Cross-linking was re-
versed by incubation at 65°C overnight and DNA was purified using the
MinElute PCR purification kit (Qiagen). PCRs for Gcm1 and matrix metallo-
proteinase 2 (MMP2) were carried out at 59°C for 35 cycles. Primers for the third
intron of murine Gcm1 generated a 236-bp product: Gcm1 5 primer, ATTCG
TGAATAAGTAGGGAGGA; Gcm1 3 primer, GCTGATTCTGAGTCTGAG
GTGTC. Primer for 2723 to 2344 in the MMP2 promoter generated a 401-bp
product. The MMP2 5 primer was CTCACAGGACCCTCACCAGAC and the
MMP2 3 primer was GCCTTAGGAAGACATGGAACCC.
RESULTS
Expression of MEKK4 in placental trophoblasts. To under-
stand the role of MEKK4 in trophoblasts, MEKK4 expression
during placental development from E7.5 to E13.5 was exam-
ined by immunostaining with an anti-MEKK4 antibody and by
in situ hybridization with an antisense probe for MEKK4.
MEKK4 is expressed strongly in the developing embryo (Fig.
1A and B) (3, 7). In addition, MEKK4 was found in the giant
cells surrounding the embryo and in the ectoplacental cone of
the E7.5 placenta by both immunostaining (Fig. 1A) and in situ
hybridization (Fig. 1B). At E8.5, robust staining for MEKK4
was observed in the chorion of the placenta (Fig. 1C, D, and
FIG. 2. Altered morphology of kinase-inactive (K1361R) placen-
tas with dysregulated expression of Tpbp. Placental sections from
littermate E9.5 embryos with wild-type (MEKK4WT; left), heterozy-
gous (MEKK4WT/K1361R; center), or homozygous kinase-inactive
(MEKK4K1361R; right) genotypes. (A) Hematoxylin and eosin
(H&E) staining of E9.5 placentas. White arrowheads indicate the
location of the placenta. (B) In situ hybridization with antisense
probe to the spongiotrophoblast marker Tpbp, showing dysregu-
lated expression of Tpbp. Open black arrows indicate sites of
Tpbp expression. (C) In situ hybridization with antisense probe to
the primary giant cell marker placental lactogen I (PlI). Bar, 0.1
mm. MEKK4 is expressed strongly in trophoblast stem cells and
expression is reduced with differentiation. (D) MEKK4 is expressed
more strongly in stem cells than in fibroblasts. Thirty micrograms of
TS cell or MEF lysate was probed with anti-MEKK4 or anti-
	
3 antibodies. (E) MEKK4 expression is reduced by TS cell
differentiation. TS cells were differentiated by removal of FGF4 and
fibroblast-conditioned medium for the indicated times and probed
with anti-MEKK4 or anti--tubulin antibodies.
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E). In situ hybridization detected MEKK4 message in all three
of the trophoblast cell layers of the E9.5 placenta that included
the labyrinth, spongiotrophoblast, and giant cell layers (Fig.
1F), but staining was not observed with a control MEKK4
sense probe (Fig. 1G). Further, anti-MEKK4 immunostaining
of E9.5 placentas revealed MEKK4 staining in all three tro-
phoblast layers, with the strongest staining in the undifferen-
tiated cuboidal trophoblasts (Fig. 1H and I). At E13.5,
MEKK4 protein and message were only weakly detectable,
indicating a loss of MEKK4 expression with placental differ-
entiation and maturation (data not shown). Costaining of E9.5
placentas with anti-PECAM antibody to detect endothelial
cells and anti-MEKK4 antibody showed that MEKK4 does not
colocalize with PECAM-positive endothelial cells but is highly
expressed in the undifferentiated trophoblasts (Fig. 1J, K, and
L). All trophoblast cells express keratins, a family of interme-
diate filament proteins. Differentiation of trophoblasts induces
the expression of a more extensive keratin scaffold network
that is detectable with a pan-anticytokeratin antibody. Costain-
ing with anticytokeratin antibody and anti-MEKK4 antibody
demonstrated colocalization of MEKK4 and cytokeratin (Fig.
1M, N, and O). However, MEKK4 expression was reduced in
the more cytokeratin-positive differentiated trophoblasts rela-
tive to the undifferentiated trophoblasts. These data indicate
that MEKK4 is highly expressed specifically in the undifferen-
tiated trophoblasts of the placenta, and with differentiation to
mature trophoblast lineages, MEKK4 expression decreases sig-
nificantly. This finding is indicative of MEKK4 playing a sig-
nificant function in trophoblasts that is lost or significantly
diminished with differentiation.
Placentas from both heterozygote and homozygote
MEKK4K1361R E9.5 embryos display spatial malformations
and dysregulated expression of Tbpb. During the study of
embryos from MEKK4WT/K1361R intercrosses, delayed devel-
opment of the kinase-inactive homozygote and heterozygote
embryos was observed. Further, resorptions were common,
with 24% of all embryos reabsorbed or in a state of resorption
(16 of 66 embryos) at E9.5. Examination of placentas from
embryos isolated at E9.5 from MEKK4WT/K1361R intercrosses
revealed spatial malformations of both placentas and decidua
of heterozygote and homozygote MEKK4 kinase-inactive pla-
centas relative to wild-type littermates (Fig. 2A). To measure
the presence of the different trophoblast cell types in the
MEKK4 kinase-inactive placentas, in situ hybridizations for
markers of the three layers of the placenta (giant cell, spon-
giotrophoblast, and labyrinth) were performed. Expression of
the spongiotrophoblast marker Tpbp was clearly elevated in
the placentas from both heterozygote and homozygote kinase-
inactive embryos, with levels being even higher in heterozy-
gotes (Fig. 2B). This finding is likely due to the dominant
negative properties of the kinase-inactive mutant and the de-
fined ability of the kinase-inactive protein to dimerize with the
wild-type protein and interfere with MEKK4 signaling to JNK
and p38, resulting in severe neural tube and skeletal defects
(3). The mRNA levels of the primary giant cell marker PlI
were only slightly increased, particularly in the homozygous
MEKK4 kinase-inactive animals (Fig. 2C), but not as dramat-
FIG. 3. Reduced E-cadherin expression in TS cells homozygous for
MEKK4K1361R. (A) Phase microscopy of wild-type and mutant TS cells
cultured under undifferentiating conditions in the presence of FGF4
and conditioned medium is shown. Wild-type TS cells colonies exist as
tight epithelial sheets. Heterozygote MEKK4WT/K1361R TS cell colo-
nies are more irregularly shaped and slightly differentiated. Homozy-
gote MEKK4K1361R TS cell colonies appear differentiated with irreg-
ularly shaped, polarized cells. Bar, 100 m. (B) E-cadherin expression
in wild-type and kinase-inactive TS cells cultured under undifferenti-
ating conditions. Cells were immunostained with anti-E-cadherin an-
tibodies (red) and nuclei were counterstained with DAPI (blue).
Strong peripheral E-cadherin staining was observed in wild-type TS
cells. Peripheral E-cadherin staining was slightly decreased in hetero-
zygote kinase-inactive TS cells and further decreased in homozygote
kinase-inactive TS cells. (C) Western blotting of whole-cell extracts
from wild-type and kinase-inactive TS cells. Blots were probed with
anti-E-cadherin and antitubulin antibodies. Changes were expressed
relative to undifferentiated wild-type TS cells. WT, wild-type cells;
HET, heterozygote kinase-inactive cells; HOM, homozygote kinase-
inactive cells. Bar, 10 m. Data shown are representative results from
three independent experiments.
TABLE 1. Genotypes of trophoblast stem cells isolated from
blastocyst outgrowths from MEKK4WT/K1361R intercrosses
Stem cell type Total no. ofoutgrowths
% with indicated genotype
Wild type Heterozygote Homozygote
Genotyped 23 39.1 52.2 8.7
Stable clones 12 58.3 41.7 0
VOL. 29, 2009 MEKK4 REPRESSES TS CELL EMT 2751
2752
ically as that observed for Tpbp (Fig. 2). In situ hybridiza-
tions for the labyrinth syncytiotrophoblast marker Gcm1
yielded weak signals, making it difficult to assess changes in this
marker (data not shown). The marked increase in Tpbp ex-
pression observed in the developing placentas from MEKK4
kinase-inactive mice indicated an abnormal trophoblast differ-
entiation response.
MEKK4 function in TS cells. TS cells were isolated from
blastocyst outgrowths according to the method of Tanaka et al.
(22) and used to define the function of MEKK4 in tropho-
blasts. Similar to the immunostaining and in situ hybridization
results observed in the developing embryo and placenta (Fig.
1), immunoblotting demonstrated that MEKK4 is expressed at
high levels in isolated TS cells relative to other cell types such
as mouse embryo fibroblasts; in contrast, the MAP3K MEKK3
is expressed similarly in these two cell types (Fig. 2D). We also
compared MEKK4 expression in vitro in wild-type renewing
TS cells versus differentiating TS cells induced by the removal
of FGF4 and fibroblast-conditioned medium. Similar to what
occurred in the placenta, induction of trophoblast differentia-
tion resulted in reduced MEKK4 expression levels (Fig. 2E).
Differentiation of TS cells resulted in increased levels of a
degradation fragment of MEKK4 that runs just below the
full-length form of MEKK4. This change was followed by a
reduction in the total levels of MEKK4 by 12 days of dif-
ferentiation, a time that yields clearly defined spongiotro-
phoblasts, syncytiotrophoblasts, and giant cells in cultures
(Fig. 2E).
TS cells were isolated from blastocyst outgrowths from 12
litters of MEKK4WT/K1361R intercrosses. Of the 61 isolated
blastocysts, 16% failed to hatch and were discarded. Of the 51
outgrowths, 73% yielded TS cell colonies, with 45% of these
clones generating enough cells to be successfully genotyped. At
this stage of isolation, there was a clear loss of TS cells ho-
mozygous for the MEKK4K1361R mutation (Table 1). The ho-
mozygote MEKK4K1361R colonies failed to stabilize and ter-
minally differentiated (Table 1). Interestingly, there was a
significant reduction in the number of heterozygote
MEKK4WT/K1361R outgrowths relative to wild-type outgrowths
that formed stable TS cell colonies (Table 1).
Due to the potential loss of homozygote MEKK4K1361R cells
due to failed hatching and attachment, we isolated TS cells
from the extraembryonic ectoderm. TS cells can be isolated
from the extraembryonic ectoderm of the E6.5 conceptus (22).
However, MEKK4K1361R embryos, including the extraembry-
onic placenta, have delayed development requiring the isola-
tion of homozygous TS cells at E7.5, a stage that is extremely
difficult to isolate in wild-type TS cells (22). As predicted, no
wild-type or heterozygous MEKK4WT/K1361R TS cells were iso-
lated at E7.5, but TS cells homozygous for kinase-inactive
MEKK4 were isolated, consistent with the MEKK4 kinase-
inactive homozygote embryos being developmentally delayed.
We were successful in obtaining stable homozygote
MEKK4K1361R TS cells that could be cultured for over 6
months.
Even in the presence of FGF4 and conditioned medium
used to maintain wild-type TS cells in an undifferentiated self-
renewing state, both the heterozygous and homozygous
MEKK4 kinase-inactive cells have a dramatically altered mor-
phology and diminished E-cadherin expression (Fig. 3). Exam-
ination of the morphology of the different TS cell populations
revealed that the wild-type TS cells grew in tight colonies of
epithelial sheets with a characteristic cobblestone appearance
(Fig. 3A). In contrast, heterozygous and homozygous MEKK4
kinase-inactive TS cells had a dramatically altered spindle-like
morphology characteristic of a mesenchymal phenotype (Fig.
3A), with the homozygous MEKK4 kinase-inactive cells having
a stronger mesenchymal cell-like morphology than the het-
erozygous cells. Figure 3B also shows that there was a substan-
tial loss of E-cadherin expression in both the heterozygous and
homozygous MEKK4 kinase-inactive TS cells under undiffer-
entiating culture conditions in the presence of FGF4 and fi-
broblast-conditioned medium. The loss of E-cadherin expres-
sion was confirmed by immunoblotting (Fig. 3C). Thus, TS
cells harboring kinase-inactive MEKK4 have the morphologi-
cal characteristics of trophoblasts differentiating into a mesen-
chymal phenotype.
Trophoblasts expressing MEKK4K1361R are highly invasive
through the extracellular matrix. Figure 4 shows that TS cells
expressing MEKK4K1361R are highly invasive through growth
factor-reduced Matrigel. Undifferentiated wild-type TS cells
are epithelial in nature and noninvasive. In contrast, TS cells
expressing even one MEKK4 kinase-inactive allele are highly
invasive (Fig. 4A). TS cells homozygous for MEKK4K1361R are
similarly highly invasive, as the heterozygous MEKK4WT/K1361R
TS cells (data not shown). Withdrawal of FGF4 and fibroblast-
conditioned medium induces wild-type TS cell differentiation
and invasion (Fig. 4A). Figure 4B quantitates the invasiveness
of undifferentiated and 2-day-differentiated wild-type and
heterozygous MEKK4 kinase-inactive trophoblasts. It is
clear that the expression of MEKK4K1361R markedly in-
creases trophoblast invasiveness in the presence or absence
of FGF4 and fibroblast-conditioned medium. Wild-type and
heterozygous MEKK4K1361R-expressing trophoblasts that
invaded and migrated through the extracellular matrix-
coated filters under differentiating conditions were collected
FIG. 4. Increased invasiveness of MEKK4 kinase-inactive TS cells. (A) Invasion of undifferentiated or differentiated wild-type and heterozygote
kinase-inactive TS cells through growth factor-reduced Matrigel. Chambers were Wright-stained and 10 images from two transwell chambers are
shown for each condition. (B) Quantitation of the TS cell invasion shown in panel A. Data shown are the means  ranges of two independent
experiments performed in duplicate. Five 32 fields were counted for each transwell chamber. (C) Increased expression of proteases in
kinase-inactive TS cells. Message levels were measured by quantitative RT-PCR of TS cells differentiated for the indicated number of days. Data
are the means  ranges of three independent experiments performed in duplicate and normalized to undifferentiated wild-type levels. (D) In-
creased expression of EMT-inducing transcription factors Slug and Twist in MEKK4 kinase-inactive TS cells. TS cells were cultured under
undifferentiating conditions in the presence of FGF4 and conditioned medium. Message levels were measured by quantitative RT-PCR. Data
normalized to wild-type undifferentiated TS cell levels are the means  ranges of two independent experiments performed in duplicate. Het,
heterozygous; Hom, homozygous.
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and used to monitor specific trophoblast marker expression
in the invading cells. The abundance of the trophoblast
markers in the invading cells was compared to that of 2-day
differentiated trophoblasts. Invading trophoblasts had elevated
Tpbp expression compared to 2-day differentiated tropho-
blasts (data not shown), suggesting that the spongiotrophoblast
marker Tpbp is strongly expressed in invasive trophoblasts.
Interestingly, elevated Tpbp was observed in the hyperinva-
sive trophoblasts in the placentas of MEKK4WT/K1361R and
MEKK4K1361R embryos (Fig. 2B).
Galardin is a specific inhibitor of MMPs (16). Incubation of
2-day differentiated wild-type and MEKK4K1361R TS cells with
galardin inhibited invasiveness 29 and 14%, respectively, indi-
cating that MMP activity was associated with invasiveness
(data not shown). To further test this hypothesis, real-time
PCR analysis was performed for specific proteases known to be
expressed by trophoblasts (14). Figure 4C shows that MMP2
and cathepsin S are elevated in both the heterozygous and
homozygous MEKK4 kinase-inactive TS cells cultured under
undifferentiating conditions. MMP9 is elevated in homozygous
but not heterozygous MEKK4 kinase-inactive trophoblasts.
Differentiation of TS cells by removal of FGF4 and condi-
tioned medium induced the expression of other proteases, like
urokinase plasminogen activator and cathepsin Q, with mes-
sage induction being significantly greater in kinase-inactive TS
cells than in wild-type cells (Fig. 4C). These findings in com-
bination with the loss of the E-cadherin, spindle-like morphol-
ogy characteristic of motile mesenchymal cells and the in-
creased invasiveness observed with inhibition of MEKK4
kinase activity demonstrate that MEKK4 regulates several cel-
lular hallmarks that define EMT.
Increased expression of the transcriptional regulators of
EMT Slug and Twist in MEKK4K1361R TS cells. Several tran-
scription factors that repress E-cadherin expression, including
Snail and bHLH families, are thought to function in develop-
ment and EMT. Snail family members include Snail1, Snail2
(Slug), and Snail3. These zinc finger transcription factors share
a common organization with similar DNA binding domains in
their C termini and are thought to act mainly as transcriptional
repressors. Snail and Slug directly repress E-cadherin expres-
sion by binding to E-box elements in the E-cadherin promoter
(5, 6). Snail and Slug are also capable of repressing the expres-
sion of several polarity genes that contribute to epithelial traits.
Twist is a bHLH transcription factor also capable of repressing
E-cadherin expression, but the mechanism is not well defined.
Twist has been shown to induce EMT in specific epithelial cell
types (25). Figure 4D shows that both Slug and Twist, but not
other EMT-inducing transcription factors, are induced in
MEKK4K1361R TS cells. Detailed analysis of the expression of
Snail, Slug, and Twist with trophoblast differentiation revealed
the induction of Snail by FGF4 withdrawal (Fig. 4D). This
induction of Snail is consistent with the EMT that occurs with
the differentiation of epithelial trophoblast stem cells into in-
vasive mesenchymal trophoblasts. Significantly, Slug and Twist,
which are overexpressed in kinase-inactive TS cells, are not
induced by trophoblast differentiation (Fig. 4D). Instead, the
overexpression of Slug and Twist by the mutant TS cells re-
flects the aberrant expression of these transcription factors.
The expression of these transcription factors indicates the
mechanism for loss of E-cadherin and the induction of EMT in
MEKK4K1361R TS cells and is consistent with the highly inva-
sive characteristics of the kinase-inactive trophoblast stem
cells.
MEKK4K1361R TS cells have inhibited JNK and p38 activi-
ties and diminished responsiveness to FGF4. MEKK4 regu-
lates the JNK and p38 MAPK pathways (1, 2). In the presence
of FGF4 and conditioned medium, levels of activated JNK and
p38 are significantly inhibited in MEKK4WT/K1361R TS cells
relative to wild-type TS cells (Fig. 5A). Whereas JNK activity
is inhibited approximately 40% in cycling TS cells expressing
MEKK4K1361R, p38 activity is almost completely inhibited
compared to wild-type TS cells. Removal of FGF4 and condi-
tioned medium resulted in a rapid decrease within minutes in
phosphorylated JNK in both wild-type and MEKK4WT/K1361R
TS cell populations (Fig. 5A), indicating that FGF4 and con-
ditioned medium sustain activation of JNK in TS cells. In
contrast, there was a measurable transient increase in p38
activity, which may be related to the stress of growth factor
withdrawal. Temporally, the loss of JNK activity was signifi-
cantly more rapid in MEKK4WT/K1361R TS cells, but by 240
min JNK activity was undetectable in both TS cell populations.
Thus, expression of kinase-inactive MEKK4 inhibits both JNK
and p38 in self-renewing TS cells, and the kinetics of loss of
JNK activity upon removal of FGF4 and fibroblast-conditioned
medium are faster in MEKK4WT/K1361R than in wild-type TS
cells. The results are consistent with MEKK4 being a primary
hub-like MAP3K in the control of JNK and p38 in TS cells.
Examination of changes in JNK and p38 activities during a
10-day period following removal of FGF4 and conditioned
medium revealed a loss in JNK activity in both wild-type and
kinase-inactive TS cells (Fig. 5B). Similar to the findings in Fig.
5A, both undifferentiated heterozygous MEKK4WT/K1361R and
homozygous MEKK4K1361R TS cells had significantly inhibited
JNK and p38 activities compared to wild-type TS cells. After 2
days of differentiation, JNK was reduced 80% in wild-type TS
cells but completely lost in kinase-inactive TS cells. JNK activ-
ity remained very low in all differentiated cell populations (Fig.
5B). However, extended differentiation times showed a recov-
ery of JNK phosphorylation after 12 days of FGF4 withdrawal,
suggesting an additional role for JNK in the late stages of
differentiation (see Fig. S1 in the supplemental material). At
12 days of differentiation, MEKK4 levels were reduced, sug-
gesting another MAP3K may regulate JNK at later stages of
differentiation (Fig. 2E). Overall, the findings indicate that the
rapid loss of JNK activity is a normal TS cell response to FGF4
and conditioned medium withdrawal and the induction of dif-
ferentiation. MEKK4 harboring the K1361R mutation, as
shown previously (2, 3), functions as an inhibitory mutant.
Figure 5 shows that expression of MEKK4K1361R inhibits JNK
and p38 activities in undifferentiated TS cells. Diminished JNK
and/or p38 activity in MEKK4K1361R TS cells appears to re-
lease the repression of differentiation that would normally
occur only with FGF4 withdrawal.
Addition of FGF4 to wild-type TS cells results in a robust
activation of JNK (12-fold) and a modest activation of p38
(Fig. 5C). FGF4-induced activation of JNK was reduced by
80% in homozygous MEKK4K1361R TS cells. Similarly, FGF4-
induced activation of p38 was completely lost in kinase-inactive
TS cells (Fig. 5C). However, kinase-inactive TS cells retained a
robust FGF4-induced activation of ERK that was similar to
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wild-type TS cells (Fig. 5C). Together, these data suggest that
MEKK4 is the primary MAP3K for FGF4 activation of JNK
and p38 in TS cells.
Chemical inhibition of JNK results in the induction of Slug
and loss of E-cadherin in undifferentiated wild-type TS cells.
Small-molecule inhibitors for JNK, p38, GSK3, MEK1/2, and
phosphatidylinositol 3-kinase were used to screen for pathways
controlling the expression of Slug (Fig. 6A) and Twist (Fig. 6B)
in wild-type TS cells cultured under undifferentiating condi-
tions. Of the inhibitors tested, only the JNK inhibitor induced
the expression of Slug. Induction of Slug expression was dose
dependent for the JNK inhibitor, consistent with a specific
small-molecule inhibition of JNK activity inducing Slug expres-
sion. In contrast, JNK inhibitor had no effect on Twist expres-
sion, providing discrimination between the regulation of Slug
and Twist by kinase-inactive MEKK4. Twist expression was
increased with the GSK3 inhibitor, but not by inhibition of
p38, MEK1/2, or phosphatidylinositol 3-kinase. Interestingly,
MEKK4 binds GSK3 (1), and it is possible that the GSK3
activity associated with its interaction with MEKK4 is involved
in the control of Twist expression. Inhibition of JNK in wild-
type TS cells resulted in increased MMP2 and cathepsin S
message levels but had negligible effects on MMP9 and
MMP14 (Fig. 6C and D and data not shown). These increases
in MMP2 and cathepsin S were similar to those observed in
kinase-inactive TS cells (compare Fig. 4C and 6C and D).
Importantly, JNK inhibition in wild-type TS cells induces a loss
of E-cadherin expression and the onset of a mesenchymal
phenotype (Fig. 6E), consistent with the induction of Slug.
Thus, JNK inhibition of wild-type TS cells is sufficient to in-
duce several hallmarks of EMT that strongly resemble kinase-
inactive TS cells.
We discovered that chemical inhibition of p38 in TS cells
results in JNK activation (data not shown). This is due
apparently to a negative feedback regulation that is unde-
fined in mechanism. The fact that chemical inhibition of p38
results in JNK activation prevents the ability to use p38 inhib-
itors in wild-type TS cells to study p38 function, because JNK
activity represses the EMT response. The combination of JNK
and p38 inhibitors was toxic to TS cells.
JNK suppresses expression of Tpbp and Gcm1 in TS cells.
Quantitative RT-PCR using probes for markers of the differ-
ent trophoblast lineages was used to further define the
properties of wild-type, heterozygote, and homozygote
MEKK4K1361R TS cell cultures (Fig. 7A). EsRR, a tropho-
blast stem cell marker, was highly abundant in both wild-type
and kinase-inactive MEKK4 TS cells (Fig. 7A). Additional TS
cell markers, like Cdx2 and Eomes, were also highly expressed
in both wild-type and kinase-inactive TS cells (data not shown).
Differentiation of TS cells by removal of FGF4 and condi-
FIG. 5. FGF4 stimulation of JNK phosphorylation is reduced in
kinase-inactive TS cells. Western blot analysis of wild-type, heterozy-
gote, and homozygote kinase-inactive TS cell extracts is shown. Blots
were probed with antibodies against phospho-JNK, phospho-p38, -tu-
bulin, -catenin, and E-cadherin. Changes are relative to wild-type TS
cells (time zero). (A) Removal of FGF4 from TS cells results in a loss
of JNK phosphorylation. FGF4 and conditioned medium was removed
for the indicated times. Phospho-JNK levels decreased after an hour of
differentiation. Phospho-JNK and phospho-p38 levels were signifi-
cantly reduced in kinase-inactive TS cells. (B) Differentiation results in
a loss of phospho-JNK protein and a slight enhancement in phospho-
p38 protein levels. Kinase-inactive TS cells exhibited a 60 to 80%
reduction in phospho-JNK levels and a nearly complete loss of phos-
pho-p38. (C) FGF4-stimulated JNK phosphorylation is diminished in
kinase-inactive TS cells. TS cell were cultured for 24 h in the absence
of FGF4 in TS medium containing TGF-. FGF4 (10 ng/ml) was
added for the indicated times. Data shown are representative results
from three independent experiments.
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tioned medium resulted in a dramatic loss of EsRR, indicat-
ing a loss of stem cell potential (Fig. 7A). Giant cells are the
default differentiation pathway and proliferin and PlI are giant
cell markers (20). Proliferin and PlI were expressed at
low levels in undifferentiated wild-type, heterozygous
MEKK4WT/K1361R, and homozygous MEKK4K1361R TS cells
(Fig. 7A). At 5 and 10 days of differentiation, a significant
increase in the message levels for the two giant cell mark-
ers was observed in wild-type, MEKK4WT/K1361R, and
MEKK4K1361R TS cells. At 10 days of differentiation, proliferin
and PlI were only slightly elevated in kinase-inactive TS cells.
Tpbp, a marker of the spongiotrophoblasts, was induced sev-
enfold in the MEKK4WT/K1361R trophoblasts after 2 days of
differentiation but remained at very low mRNA levels in wild-type
trophoblasts. Further differentiation of trophoblasts for 5 to 10
days resulted in increased Tpbp message. Strikingly, Tpbp
FIG. 6. Chemical inhibition of JNK induces the expression of Slug, MMP2, and cathepsin S and a loss of E-cadherin expression. (A, B, C, and
D) Wild-type TS cells were cultured under undifferentiating conditions in the presence of FGF4 and conditioned medium and treated for 2 days
with either DMSO, 30 M GSK3 inhibitor, JNK inhibitor, 10 M p38 inhibitor, 20 M MEK inhibitor, 0.1 M wortmannin, or differentiated
(Diff) for 2 days in the absence of FGF4 and conditioned medium. Message levels were measured by quantitative RT-PCR. Data were normalized
to wild-type undifferentiated DMSO-treated TS cell levels. Data are the means  ranges of two independent experiments performed in duplicate.
(E) Wild-type TS cells cultured under undifferentiating conditions were treated for 2 days with either DMSO, 10 M SB203580 (p38 inhibitor),
or 50 M SP600125 (JNK inhibitor). Cells were immunostained with anti-E-cadherin antibody (red) and nuclei were counterstained with DAPI
(blue). Strong peripheral E-cadherin staining in wild-type TS cells treated with DMSO or p38 inhibitor was lost with JNK inhibitor treatment. Data
shown are representative images from three independent experiments. Wt, wild type. Bar, 10 m.
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message was consistently higher in the MEKK4WT/K1361R and
MEKK4K1361R trophoblasts than in wild-type cells at all stages
of differentiation (Fig. 7A). This increase in Tpbp levels in
mutant TS cells is similar to those increases observed in kinase-
inactive mutant placentas (compare Fig. 2B and 7A). Gcm1, a
syncytiotrophoblast marker, is expressed at low levels in undif-
ferentiated wild-type TS cells. Gcm1 message was dramatically
upregulated in undifferentiated kinase-inactive TS cells, with a
10-fold and 38-fold increase in basal expression of Gcm1 in
MEKK4WT/K1361R and MEKK4K1361R TS cells, respectively,
relative to wild-type TS cells (Fig. 7A). Differentiation of wild-
type TS cells for 2 days resulted in a 25-fold increase in Gcm1
levels; with further differentiation, Gcm1 levels returned to the
low levels observed in undifferentiated cells (Fig. 7A). Differ-
entiation of kinase-inactive TS cells resulted in a 435-fold and
158-fold elevation in Gcm1 message in MEKK4WT/K1361R and
MEKK4K1361R TS cells, respectively, in direct contrast to the
25-fold change observed in wild-type TS cells (Fig. 7A). Fur-
ther differentiation for 5 to 10 days resulted in the loss of Gcm1
expression, indicating that the pathways controlling the return
of Gcm1 mRNA levels function similarly in both the wild-type
and kinase-inactive trophoblasts. The morphological changes
and altered expression of trophoblast markers indicated that
the heterozygous and homozygous MEKK4 kinase-inactive TS
cells have a diminished capacity to sustain maintenance of the
undifferentiated TS cell phenotype and to repress differentia-
tion toward the spongiotrophoblast and syncytiotrophoblast
lineages.
MEKK4WT/K1361R and MEKK4K1361R TS cells have signifi-
cantly inhibited JNK and p38 activities (Fig. 5). Therefore,
undifferentiated wild-type TS cells were treated for 2 days with
inhibitors for JNK, p38, or MEK1/2 as controls and expression
of trophoblast cell type markers was analyzed by quantitative
RT-PCR (Fig. 7B). Inhibition of JNK produced a modest de-
crease in the stem cell marker EsRR and had no or little
effect on the giant cell markers PlI and proliferin (Fig. 7B). In
striking contrast, dramatic increases in the message levels of
both spongiotrophoblast (Tpbp) and syncytiotrophoblast
(Gcm1) markers were observed with JNK inhibition but not
with inhibition of p38 or MEK1/2 (Fig. 7B). The induction of
Gcm1 and Tpbp was dose dependent for SP600125, indicat-
ing that JNK activity directly correlates with inhibition of
FIG. 7. JNK inhibition deregulates Tpbp and Gcm1 expression in
kinase-inactive TS cells. (A) Message levels were measured by quan-
titative RT-PCR of TS cells differentiated for the indicated number of
days. Data are the means  ranges of between two and five indepen-
dent experiments performed in duplicate. Data were normalized to
wild-type undifferentiated TS cell levels. (B) Inhibition of JNK with
SP600125 in undifferentiated wild-type TS cells induces the deregula-
tion of Tpbp and Gcm1. Wild-type TS cells were treated for 2 days
under undifferentiating conditions with DMSO (Undiff), 50 M
SP600125 (JNK inhibitor), 10 M SB203580 (p38 inhibitor), 10 M
U0126 (MEK inhibitor), or under differentiating conditions with
DMSO (Diff). Message levels were measured by quantitative RT-PCR.
Data are the means  ranges of between two and four independent
experiments performed in duplicate. Data were normalized to wild-
type undifferentiated levels. (C) Dose-dependent effects of JNK inhib-
itor SP600125 on Gcm1 and Tpbp message levels. Wild-type TS cells
were treated for two days with the indicated concentration of
SP600125. mRNA levels were measured as for panel A.
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FIG. 8. JNK inhibition alters AP-1 composition in TS cells. (A) Jun B and Fra-1 protein levels are significantly reduced in kinase-inactive TS
cells. Results from Western blot analysis of nuclear lysates from wild-type and heterozygote kinase-inactive TS cells differentiated for the indicated
times are shown. Blots were probed with antibodies against JunB, Fra-1, Fra-2, and -catenin. Changes are relative to undifferentiated wild-type
TS cells (time zero). (B) Fra-1 and JunB mRNA levels are significantly reduced in kinase-inactive TS cells. Fra-1 and JunB mRNA levels were
measured by quantitative RT-PCR of TS cells differentiated for the indicated number of days. Data are the means  ranges of two experiments.
Data were normalized to wild-type undifferentiated levels. (C) Inhibition of JNK with SP600125 in undifferentiated TS cells induces the loss of
Fra-1 message. Wild-type TS cells were treated for 2 days under undifferentiating conditions with DMSO (Undiff), 50 M SP600125 (JNK
inhibitor), or under differentiating conditions with DMSO (Diff). Fra-1 and JunB mRNA levels were measured by quantitative RT-PCR. Data are
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Tpbp and Gcm1 expression (Fig. 7C). In contrast, p38 or
MEK1/2 inhibition did not enhance the expression of any tro-
phoblast cell type markers but actually decreased expression of
the giant cell markers (PlI and proliferin) (Fig. 7B). Activity of
p38 is markedly inhibited in MEKK4WT/K1361R and
MEKK4K1361R TS cells, but unlike inhibition of JNK, inhibi-
tion of p38 is not critical for regulation of Tpbp and Gcm1
expression. Interestingly, inhibition of the ERK1/2 pathway
with the MEK1/2 inhibitor U0126 caused a complete loss of
the stem cell marker EsRR in the TS cells (Fig. 7B), suggest-
ing an important function of ERK1/2 in EsRR expression.
Cumulatively, these data indicate that JNK signaling selec-
tively inhibits expression of Tpbp and Gcm1. Further, it is the
reduced JNK activity in TS cells expressing the kinase-inactive
MEKK4 mutant protein, and not the loss of p38 activity, which
is responsible for the enhanced Tpbp and Gcm1 expression in
kinase-inactive TS cells.
MEKK4 stimulation of JNK regulates AP-1 composition in
TS cells. Loss of specific MAP3K signaling dramatically alters
the expression of specific AP-1 complex proteins, resulting in
changes in promoter-bound AP-1 composition and gene ex-
pression (8, 12, 13). We defined the expression of specific Jun
and Fos proteins in wild-type and MEKK4WT/K1361R TS cells
during trophoblast differentiation. The expression levels of
ATF-2, c-Jun, and c-Fos were similar in wild-type and MEKK4
kinase-inactive TS cells (data not shown). In contrast, the ex-
pression levels of Fra-1, Fra-2, and JunB were altered (Fig.
8A). Expression levels of Fra-1 and JunB were inhibited and
expression of Fra-2 was increased in MEKK4 kinase-inactive
TS cells relative to wild-type TS cells.
Quantitative RT-PCR analysis demonstrated that Fra-1 and JunB
mRNA expression levels were reduced in MEKK4WT/K1361R TS
cells (Fig. 8B). Inhibition of JNK in wild-type TS cells resulted
in a strong inhibition of Fra-1 mRNA expression, indicating
that JNK regulates the mRNA levels for Fra-1 (Fig. 8C). Un-
like Fra-1, JNK inhibition had a weak effect on JunB mRNA
levels. Binding of inactive JNK to JunB has been shown to
promote the ubiquitination and degradation of JunB (12), and
JNK has also been shown to activate the E3 ubiquitin ligase Itch,
resulting in degradation of JunB and c-Jun in T cells (13). Pro-
teasome inhibition using MG132 modestly increased JunB pro-
tein in both MEKK4WT/K1361R and wild-type TS cells (Fig. 8D),
suggesting that altered proteasome-mediated degradation is
not the major mechanism for regulating JunB protein levels in
TS cells. Changes in JunB expression appear to be regulated by
MEKK4 largely independently of JNK activity in TS cells.
To define the consequence of changes in Fra-1, Fra-2, and
JunB expression, the binding of AP-1 components to the Gcm1
promoter was analyzed by ChIP (Fig. 8E and F). A consensus
AP-1 site (TGA G TCA) is present in the third intron of the
mouse Gcm1 gene that is absolutely conserved in the third
intron of the human Gcm1 gene. ChIP revealed the binding of
Fra-1, Fra-2, and JunB to the third intron of Gcm1 in wild-type
undifferentiated TS cells (Fig. 8E). Reduced binding of Fra-1
and JunB and increased Fra-2 binding to the Gcm1 intron 3 in
MEKK4WT/K1361R TS cells were observed (Fig. 8E and F).
ChIP analysis of a consensus AP-1 site (TGA C TCA) in the
MMP2 promoter revealed similar findings. A twofold increase
in Fra-2 binding to the MMP2 promoter in MEKK4K1361R TS
cells relative to wild-type TS cells was observed (Fig. 8G and
H). Thus, loss of MEKK4 kinase activity changes the AP-1
repertoire binding to intron 3 of Gcm1 and the promoter of
MMP2. These changes in AP-1 composition probably contrib-
ute to the dysregulated expression of these proteases in
MEKK4 kinase-inactive TS cells. Cumulatively, the results de-
fine FGF4-stimulated MEKK4 regulation of JNK activity as
the mechanism for repression of TS cell commitment to EMT
and differentiation.
DISCUSSION
It is well known that FGF4 and TGF/activin along with
other undefined factors maintain TS cells in a self-renewing
state that includes repression of differentiation (18, 26). Even
though FGF4 activation of ERK1/2 has defined antiapoptotic
functions in TS cell renewal (26), signals promoting repression
of differentiation, including trophoblast EMT, have not been
characterized. MEKK4 is highly expressed in TS cells and
MEKK4 expression is significantly reduced during differentia-
tion, positioning MEKK4 as an important MAP3K in control-
ling TS cell function. MEKK4 is a 180-kDa serine/threonine
protein kinase that interacts with several proteins known to
regulate EMT, including GSK3 (1, 9), Cdc42 and Rac (11),
axin, the negative regulator of -catenin (17), and NIK, the
NCK-interacting kinase (A. N. Abell and G. L. Johnson, un-
published data). MEKK4 signals to activate both JNK and p38
(1, 3). Our results clearly show that MEKK4 kinase activity is
required for FGF4-stimulated JNK and p38 activities in TS
cells. Kinase-inactive MEKK4 TS cells selectively differentiate
to spongiotrophoblasts and syncytiotrophoblasts even in the
presence of FGF4 and fibroblast-conditioned medium, indicat-
ing that MEKK4 signaling is essential for repression of differ-
entiation. A major phenotype of the differentiation response
observed with expression of kinase-inactive MEKK4 was EMT
the means  ranges of between two and four independent experiments. Data were normalized to wild-type undifferentiated levels. (D) Treatment
with the proteasome inhibitor MG132 does not restore Fra-1 levels in kinase-inactive TS cells. Undifferentiated TS cells were treated with DMSO
or MG132 for 5 hours and analyzed as described for panel A. (E) Alteration in AP-1 family member binding to the third intron of Gcm1 in
undifferentiated MEKK4WT/K1361R cells. ChIP analysis was performed using antibodies to Fra-1, Fra-2, and JunB using samples obtained from
undifferentiated MEKK4WT and MEKK4WT/K1361R TS cells. PCR was performed to a region containing an AP-1 consensus sequence (TGA G
TCA) in the third intron of Gcm1. KI, kinase inactive. (F) Quantitation of ChIP analysis of Gcm1. Data shown are the means  ranges of between
two and three experiments. Bands were quantitated by densitometry using ImageJ and data were normalized to wild-type levels. (G) Alteration
of AP-1 family member binding to the MMP2 promoter in undifferentiated MEKK4K1361R cells. ChIP analysis was performed with antibodies to
Fra-1 and Fra-2 using samples obtained from undifferentiated MEKK4WT and MEKK4K1361R TS cells. PCR was performed to a region in the
MMP2 promoter (2723 to 2344) containing an AP-1 consensus sequence (TGA C TCA). (H) Quantitation of ChIP analysis results with the
MMP2 promoter. Data shown are the means  standard errors of the means of three experiments.
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characterized by increased Slug, Twist, MMP2, and cathepsin
S, loss of E-cadherin expression, and increased invasiveness.
The p38 MAPK has been shown to regulate EMT during
gastrulation and is downstream of a signaling pathway involv-
ing NIK (28), which is a MEKK4 binding partner. A p38-
interacting protein (p38IP) required for p38 activation in vivo
is required for downregulation of E-cadherin during gastrula-
tion. The p38IP was also found to be involved in neural tube
closure, with p38IP mutants having exencephaly and spina
bifida (28). Interestingly, MEKK4 kinase-inactive and knock-
out mice have defects in p38 activation and display both exen-
cephaly and spina bifida (3). The p38 MAPK is also implicated
in tumor cell EMT, particularly in response to transforming
growth factor  (TGF-) and in some cases tumor necrosis
factor alpha.
JNK does not appear to be involved in EMT during gastru-
lation but is implicated as a positive regulator of TGF--in-
duced EMT in several cell types (15, 19). Genetically, it was
recently shown that TGF--stimulated EMT of primary mu-
rine tracheal epithelial cells was markedly blunted in a
JNK1/ background but not a JNK2/ background (4). The
role of JNK in positively regulating EMT in different cell types
seems to involve AP-1 and the regulation of cadherins and
specific Smads (4). Little is known about the role of JNK in
controlling the EMT response in tissue stem cells.
Our results show that JNK is strongly activated by FGF4. TS
cell differentiation induced by withdrawal of FGF4 results in a
loss of JNK activity. Inhibition of JNK in TS cells by kinase-
inactive MEKK4 or by chemical inhibition promotes the selec-
tive differentiation of cells to the spongiotrophoblast and syn-
cytiotrophoblast lineages. These data define a clear role for
FGF4 activation of JNK in repression of EMT, a JNK function
that is clearly different from the positive regulation of TGF--
initiated EMT responses in cultures of primary tissue epithelial
cells and many transformed cell lines. Primary factors in fibro-
blast-conditioned medium for maintenance of TS cell renewal
include TGF-/activin (10), which in combination with FGF4
maintain TS cells in an undifferentiated, self-renewing state.
This is an unusual function for TGF- in primary epithelial
cells, where TGF- often inhibits proliferation of primary ep-
ithelial cells via a G1 cell cycle arrest program (23). Transfor-
mation can alter this control and bypass the G1 cell cycle arrest
in response to TGF- (23). Constitutive FGF4 signaling in TS
cells has been shown to suppress the growth inhibitory effects
of TGF-/activin, and removal of FGF4 initiates a trophoblast
differentiation program involving TGF- (10). Mechanistically,
loss of MEKK4 kinase activity removes a critical signaling
response that is needed for FGF4 to control the response of
other cytokines, such as TGF-/activin. Our findings are con-
sistent with the work of Erlebacher et al., who proposed that
FGF4 signaling in TS cells inhibited specific TGF- responses
(10). Our findings demonstrate that FGF4 inhibition of TS cell
differentiation requires MEKK4 activation of JNK. The in-
creased expression of Gcm1 and MMP2 in MEKK4 kinase-
inactive TS cells, whose expression is also induced by JNK
inhibition, is consistent with a transcriptional repressor func-
tion for MEKK4-JNK signaling in FGF4 control of TS cell
differentiation.
The function of MEKK4 control of JNK activity in TS cells
in vivo is also consistent with our findings that MEKK4 kinase-
inactive trophoblasts have an abnormal differentiation re-
sponse during placentation. Normally, a gradient of FGF4 is
generated by the developing embryo that controls trophoblast
differentiation. However, in MEKK4 kinase-inactive tropho-
blasts the TS cells do not signal properly and have a dysregu-
lated differentiation response. MEKK4 expression is highest in
the developing embryo and particularly in TS cells, and expres-
sion is dramatically diminished during differentiation. High
MEKK4 expression in renewing TS cells and loss of expression
during differentiation is consistent with the necessary function
of MEKK4 as a critical hub kinase in the maintenance of TS
cell renewal.
Finally, our results have significant implications in under-
standing the integrated signaling responses for control of tissue
stem cell maintenance, repression of differentiation, and
changes in signaling for commitment of stem cells to differen-
tiate. Kinases such as MEKK4 function as hubs that respond to
different stimuli for the selective activation of pathways within
a signaling network. MEKK4 coordinates the activity of the
JNK and p38 modules in TS cells required for stem cell main-
tenance. It is likely that kinases other than MEKK4 will have
similar functions in different tissue stem cells, and such hub
kinases will control signal networks that integrate the complex
cytokine profiles present in different stem cell niches. Identi-
fying the kinases with hub-like functions such as MEKK4 will
allow a rational chemical biology approach for selectively con-
trolling renewal and differentiation of tissue stem cells from
different tissues.
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